Receptos has established an R&D collaboration with Ono Pharmaceutical for small molecule modulators of an undisclosed G-protein coupled receptor (GPCR) target. Receptos will use its proprietary technology platform to produce high resolution protein crystal structures of the discovery target and drive Ono’s structure-based drug design efforts. Ono will pay an undisclosed upfront payment, as well as research funding and milestone payments. “The selection of a collaborative target ...